108 related articles for article (PubMed ID: 417485)
1. [Hemostasiology. Antifibrinolytic mechanisms of the liver].
Jedrychowski A; Parbhoo SP; Hillenbrand P
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1139-42. PubMed ID: 417485
[No Abstract] [Full Text] [Related]
2. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
Félez J; Rueda F
Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
[No Abstract] [Full Text] [Related]
3. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
Thromb Haemost; 1988 Oct; 60(2):247-50. PubMed ID: 3146141
[TBL] [Abstract][Full Text] [Related]
4. Natural inhibitors of fibrinolysis.
Collen D
J Clin Pathol Suppl (R Coll Pathol); 1980; 14():24-30. PubMed ID: 6448870
[No Abstract] [Full Text] [Related]
5. [Plasminogen activator inhibitors from neoplastic tissues].
Mirowski M; Wierzbicki R
Postepy Hig Med Dosw; 1991; 45(1-2):119-27. PubMed ID: 1923993
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
[TBL] [Abstract][Full Text] [Related]
7. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
Clemmensen I; Thorsen S; Müllertz S
Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
[TBL] [Abstract][Full Text] [Related]
8. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
Bachmann F
Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
[TBL] [Abstract][Full Text] [Related]
9. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
Thorsen S
Dan Med Bull; 1977 Oct; 24(5):189-206. PubMed ID: 908205
[No Abstract] [Full Text] [Related]
10. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
[TBL] [Abstract][Full Text] [Related]
11. Extrinsic plasminogen activator: a new principle in fibrinolysis.
Lijnen HR
Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
[TBL] [Abstract][Full Text] [Related]
12. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].
Matsuda T
Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968
[No Abstract] [Full Text] [Related]
13. Increased plasma levels of urokinase-type plasminogen activator with endometrial and cervical cancer.
Koelbl H; Kirchheimer JC; Tatra G; Christ G; Binder BR
Obstet Gynecol; 1988 Aug; 72(2):252-6. PubMed ID: 3134631
[TBL] [Abstract][Full Text] [Related]
14. Effect of caffein ingestion on plasma fibrinolytic potential.
Wojta J; Kirchheimer JC; Peska MG; Binder BR
Thromb Haemost; 1988 Apr; 59(2):337-8. PubMed ID: 3133816
[No Abstract] [Full Text] [Related]
15. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies on human activators of plasminogen.
Mackie M; Booth NA; Bennett B
Br J Haematol; 1981 Jan; 47(1):77-90. PubMed ID: 6449216
[TBL] [Abstract][Full Text] [Related]
18. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
Gurewich V; Pannell R
Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707
[No Abstract] [Full Text] [Related]
19. Influence of ethanol and acetaldehyde on fibrinolytic system (examinations in vitro).
Skrzydlewska E; Worowski K
Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():163-73. PubMed ID: 6242841
[No Abstract] [Full Text] [Related]
20. [Additional potentials of a method of standard fibrin plates].
Kovalenko AN
Lab Delo; 1980; (10):615-8. PubMed ID: 6158612
[No Abstract] [Full Text] [Related]
[Next] [New Search]
